Clinical Trials
5 trialsNCT03866382 2026-05-26
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT04289779 2024-12-04
ABATE
Hoosier Cancer Research Network
Phase 2 Active not recruiting
NCT03534804 2024-11-26
PemCab
University of Utah
Phase 2 Completed
NCT01688999 2022-10-18
Cabozantinib for Advanced Urothelial Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03824691 2021-02-25
ARCADIA
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown